TLTFF (Theralase Technologies) Total Assets : $2.28 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Theralase Technologies Total Assets?

Theralase Technologies's Total Assets for the quarter that ended in Dec. 2024 was $2.28 Mil.

During the past 12 months, Theralase Technologies's average Total Assets Growth Rate was -7.90% per year. During the past 3 years, the average Total Assets Growth Rate was 9.70% per year. During the past 5 years, the average Total Assets Growth Rate was 4.40% per year. During the past 10 years, the average Total Assets Growth Rate was 1.40% per year.

During the past 13 years, Theralase Technologies's highest 3-Year average Total Assets Growth Rate was 1376.40%. The lowest was -28.20%. And the median was -0.90%.

Total Assets is connected with ROA %. Theralase Technologies's annualized ROA % for the quarter that ended in Dec. 2024 was -110.61%. Total Assets is also linked to Revenue through Asset Turnover. Theralase Technologies's Asset Turnover for the quarter that ended in Dec. 2024 was 0.12.

Theralase Technologies Total Assets Historical Data

The historical data trend for Theralase Technologies's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Total Assets Chart

Theralase Technologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

7.82

4.65

3.06

2.44

2.28

Theralase Technologies Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial															2.44	2.40	2.47	2.38	2.28

Theralase Technologies Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Theralase Technologies's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	1.451	+	0.828
	=	2.28

Theralase Technologies's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	1.451	+	0.828
	=	2.28

Theralase Technologies (OTCPK:TLTFF) Total Assets Explanation

Total Assets is connected with ROA %.

Theralase Technologies's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	-2.576	/	( (2.379	+	2.279)	/ 2 )
	=	-2.576	/	2.329
	=	-110.61 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Theralase Technologies's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	0.288	/	( (2.379	+	2.279)	/ 2 )
=	0.288	/	2.329
=	0.12

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Theralase Technologies Total Assets Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Theralase Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (OTCPK:TLTFF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

TTX:Germany TLT:Canada

Address

41 Hollinger Road, Toronto, ON, CAN, M4B 3G4

Website

https://www.theralase.com

Theralase Technologies Inc brings CLT to patients and personalized ACT to patients based on individual tissue characteristics. It is two separate reportable operating divisions; the Drug Division and the Device Division. The Drug Division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs), and activates them with proprietary and patent-pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The Device Division designs develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the Food and Drug Administration (FDA) for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions.